Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of two different doses of dexmedetomidine after endotracheal intubation
IRCT20160307026950N15Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dexmedetomidine in Abnormality of blood pressure regulation and arrhythmogenic cardiomyopathy (ACM) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Blood pressure changes after endotracheal intubation and Heart rate changes after endotracheal intubation. Started Mar 2018; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Abnormality of blood pressure regulationarrhythmogenic cardiomyopathy (ACM)
Beyond the preview
Go deeper on IRCT20160307026950N15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N15.